Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Liso

Showing results (91-100 of 139) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|March 7, 2006
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantationV Pavone, F Gaudio, G Console, et al.
Annals of Hematology|April 23, 2003
FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experienceD Pastore, G Specchia, P Carluccio, et al.
Haematologica|June 1, 1979
Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric studyF Mandelli, S Amadori, F Fabiani, et al.
Acta Haematologica|August 31, 2001
Retinal abnormalities in newly diagnosed adult acute myeloid leukemiaG Specchia, F Albano, S Guerriero, et al.
European Journal of Haematology|January 1, 1989
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemiaA Erroi, G Specchia, V Liso, et al.
Cancer Genetics and Cytogenetics|October 15, 1994
Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two casesS Tosi, S Stilgenbauer, G Giudici, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection ProgramF Menichetti, P Martino, G Bucaneve, et al.
Leukemia|February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative GroupA M Carella, P Carlier, E Pungolino, et al.
Lancet (London, England)|September 21, 1985
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern EuropeF Pandolfi, V Manzari, G De Rossi, et al.
Leukemia Research|January 1, 1991
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patientsM Limonta, P Ubezio, C V Catapano, et al.
Pageof 14

Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|March 7, 2006
Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantationV Pavone, F Gaudio, G Console, et al.
Annals of Hematology|April 23, 2003
FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experienceD Pastore, G Specchia, P Carluccio, et al.
Haematologica|June 1, 1979
Treatment of acute nonlymphocytic leukemia (ANLL) in elderly patients. Results of a multicentric studyF Mandelli, S Amadori, F Fabiani, et al.
Acta Haematologica|August 31, 2001
Retinal abnormalities in newly diagnosed adult acute myeloid leukemiaG Specchia, F Albano, S Guerriero, et al.
European Journal of Haematology|January 1, 1989
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemiaA Erroi, G Specchia, V Liso, et al.
Cancer Genetics and Cytogenetics|October 15, 1994
Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two casesS Tosi, S Stilgenbauer, G Giudici, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1994
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection ProgramF Menichetti, P Martino, G Bucaneve, et al.
Leukemia|February 1, 1993
Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia. The GIMEMA Cooperative GroupA M Carella, P Carlier, E Pungolino, et al.
Lancet (London, England)|September 21, 1985
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern EuropeF Pandolfi, V Manzari, G De Rossi, et al.
Leukemia Research|January 1, 1991
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patientsM Limonta, P Ubezio, C V Catapano, et al.
Pageof 14